Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way
- PMID: 19732715
- DOI: 10.1016/j.ccr.2009.08.012
Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way
Abstract
Very little is known about how acquired oncogenic mutations arise. In this issue of Cancer Cell, Klemm and colleagues present evidence supporting a role for the antibody diversification enzyme activation-induced deaminase (AID) in the generation of mutations associated with disease progression and drug resistance in chronic myeloid leukemia.
Comment on
-
The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia.Cancer Cell. 2009 Sep 8;16(3):232-45. doi: 10.1016/j.ccr.2009.07.030. Cancer Cell. 2009. PMID: 19732723 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
